851086-86-7Relevant academic research and scientific papers
COMPOSITIONS OF CHOLINESTERASE INHIBITORS
-
Page/Page column 15, (2010/10/19)
The present invention is directed to compositions, methods of use, and processes for the synthesis related to 3-((S)-1-(dimethylamino)ethyl)phenyl methyl-((R)-1-phenylpropan-2 yl)carbamate, and its pharmaceutically acceptable salt forms, including the hydrogen fumarate salt. The present invention also relates to a novel form polymorph of 3-((S)-1-(dimethylamino)ethyl)phenylmethyl-((R)-1-phenylpropan-2 yl)carbamate, characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well a unique crystalline structure.
STIGMINE CONJUGATES FOR SUBSTANCE USE DISORDERS
-
Page/Page column 29-30, (2010/04/03)
The invention relates to methods for the treatment or prevention of substance use disorders.
Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition
Verheijen, Jeroen C.,Wiig, Kjesten A.,Du, Shoucheng,Connors, Stacie L.,Martin, Ashley N.,Ferreira, Jennifer P.,Slepnev, Vladimir I.,Kochendoerfer, Ulrike
scheme or table, p. 3243 - 3246 (2010/08/06)
Conjugation of the phenol derived from rivastigmine with amphetamines gave access to novel carbamate cholinesterase inhibitors. All compounds possessed increased affinity and selectivity for AChE compared to rivastigmine and were orally bioavailable. Comp
Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents
-
Page/Page column 20, (2008/06/13)
Carbamoyl esters inhibit cholinesterase activity and, upon hydrolysis release a pharmacologically active agent. In one embodiment, the carbamoyl ester has the following structure: wherein A is selected from the group consisting of an unsubstituted aryl, a substituted aryl, an unsubstituted heteroaryl and a substituted heteroaryl. The carbamoyl esters are employed in methods to treat an individual. The pharmacologically active agent obtained by hydrolysis of the carbamoyl esters can treat, for example, a nervous system condition, a cholinergic deficiency and conditions or diseases associated with a deficiency in a pharmacologically active agent, such as acetylcholine.
